We are excited to announce the launch of Pharmaceuticals & Nanotech Connect, a peer-reviewed, open-access journal dedicated to publishing cutting-edge research at the intersection of pharmaceutical sciences and nanotechnology.

The journal is led by Editor-in-Chief Professor Mahmoud Fahmy Elsabahy, Vice President for Graduate Studies and Research at Badr University, Cairo, Egypt. Professor Elsabahy is an internationally recognized expert in pharmaceutical technology and nanomedicine, with over 20 years of experience in gene therapy and nanomedicine. He has authored more than 130 high-impact publications, received numerous prestigious awards, served as principal investigator on several funded grants, and holds multiple patents in Europe and the United States.

Under his leadership, Pharmaceuticals & Nanotech Connect offers a dynamic platform for researchers, scholars, and professionals to share innovative contributions that advance drug development, delivery, efficacy, and safety—including nanoscale technologies that pave the way for future scientific breakthroughs.

We sincerely thank Professor Elsabahy for his vision and leadership in establishing this journal. We warmly invite researchers and professionals to submit their work and join the journal as authors or editorial board members, contributing to the advancement of pharmaceutical and nanotechnology research.